There are 2789 resources available
No
Presenter: Matthias Preusser
Session: Should radiotherapy be considered for the initial treatment of brain metastases regarding its possible immunogenic booster effect?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Emilie Le Rhun
Session: Should radiotherapy be considered for the initial treatment of brain metastases regarding its possible immunogenic booster effect?
Resources:
Slides
Webcast
Q&A
Presenter: Emilie Le Rhun
Session: Should radiotherapy be considered for the initial treatment of brain metastases regarding its possible immunogenic booster effect?
Resources:
Slides
Webcast
Discussion 228MO and 229MO
Presenter: Maria Vittoria Dieci
Session: Mini oral session - Breast cancer, metastatic
Resources:
Slides
Webcast
Discussion 230MO, LBA18 and LBA19
Presenter: Sung-Bae Kim
Session: Mini oral session - Breast cancer, metastatic
Resources:
Slides
Webcast
Discussion 387MO, 388MO and 389MO
Presenter: Clara Montagut Viladot
Session: Mini oral session - Gastrointestinal tumours, colorectal
Resources:
Slides
Webcast
Discussion 390MO and 391MO
Presenter: Astrid Lièvre
Session: Mini oral session - Gastrointestinal tumours, colorectal
Resources:
Slides
Discussion 1151MO and 1732MO
Presenter: Michael Thomas
Session: Mini oral session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
657MO - Antibiotic (ATB) therapy and outcome from nivolumab (N) in metastatic renal cell carcinoma (mRCC) patients (pts): Results of the GETUG-AFU 26 NIVOREN multicentric phase II study
Presenter: Lisa Derosa
Session: Mini oral session - Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
1505MO - Improving cancer care through broader access to quality biomarker testing: An IQN Path, ECPC and EFPIA initiative
Presenter: Nicola Normanno
Session: Mini oral session - Public policy
Resources:
Abstract
Slides
Webcast